UNSPSC 51362802: Etaqualone

This classification denotes a sedative and hypnotic with the molecular formula C17H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HFS3HB32J7, chemically known as 4(3h)-quinazolinone, 3-(o-ethylphenyl)-2-methyl- but generally known as etaqualone, which bears US NIH Compound Identifier 23914. European Medicines Agency schedules Etaqualone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07263MIG. The term ETAQUALONE is an International Non-Proprietary Name.

UNSPSC 51362802 Etaqualone, a Commodity code, does not reflect the actual work state and local governments are soliciting under this classification. The three recent opportunities posted under the code involve naloxone procurement, direct-to-manufacturer pharmacy programs, and generic multi-source pharmaceutical distribution—none of which center on etaqualone or match the code's nominal scope. The mismatch suggests either a cataloging error at the source or that the code is being used as a catch-all for pharmaceutical procurement outside its intended narrow product focus.

Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, through quarterly deliveries to its Community Health Building in Sanford. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor intelligence on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, released RFP S1070000015802 on January 20, 2026, seeking manufacturers of generic multi-source pharmaceuticals and OTC products for distribution across participating state and local facilities, including Oregon, with proposals due March 26, 2026. Issuers span county health departments, state human services agencies, and multi-state cooperative purchasing vehicles. The code shows recent activity in Florida, Texas, and Minnesota, though the pharmaceutical procurement activity does not substantiate the etaqualone classification itself.